Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aarti Drugs is an Indian pharmaceutical manufacturing company focused on commercial-scale production of small-molecule active pharmaceutical ingredients, pharma intermediates, specialty chemicals, and finished formulations through its subsidiary Pinnacle Life Science. The company is part of the Aarti Group and has operated since 1984, with manufacturing and R&D infrastructure centered in Maharashtra, India. Its portfolio includes established generic APIs such as ciprofloxacin hydrochloride, metronidazole, metformin hydrochloride, ketoconazole, and ofloxacin, and it serves domestic and export markets. In addition to APIs, Aarti Drugs offers contract manufacturing and produces specialty chemicals and amines used in pharmaceutical and chemical value chains. The business is primarily a commercial manufacturing and export platform rather than a clinical-stage drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aarti Drugs.